These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 22094641

  • 1. Levels of kinesin light chain and dynein intermediate chain are reduced in the frontal cortex in Alzheimer's disease: implications for axoplasmic transport.
    Morel M, Héraud C, Nicaise C, Suain V, Brion JP.
    Acta Neuropathol; 2012 Jan; 123(1):71-84. PubMed ID: 22094641
    [Abstract] [Full Text] [Related]

  • 2. Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin-1 and dynein function during axonal transport.
    Dolma K, Iacobucci GJ, Hong Zheng K, Shandilya J, Toska E, White JA, Spina E, Gunawardena S.
    Hum Mol Genet; 2014 Mar 01; 23(5):1121-33. PubMed ID: 24105467
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
    Folwell J, Cowan CM, Ubhi KK, Shiabh H, Newman TA, Shepherd D, Mudher A.
    Exp Neurol; 2010 Jun 01; 223(2):401-9. PubMed ID: 19782075
    [Abstract] [Full Text] [Related]

  • 10. LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer's disease brains.
    Mórotz GM, Glennon EB, Gomez-Suaga P, Lau DHW, Robinson ED, Sedlák É, Vagnoni A, Noble W, Miller CCJ.
    Acta Neuropathol Commun; 2019 May 08; 7(1):73. PubMed ID: 31068217
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endogenous GSK-3/shaggy regulates bidirectional axonal transport of the amyloid precursor protein.
    Weaver C, Leidel C, Szpankowski L, Farley NM, Shubeita GT, Goldstein LS.
    Traffic; 2013 Mar 08; 14(3):295-308. PubMed ID: 23279138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Atlas stumbled: kinesin light chain-1 variant E triggers a vicious cycle of axonal transport disruption and amyloid-β generation in Alzheimer's disease.
    Gan KJ, Morihara T, Silverman MA.
    Bioessays; 2015 Feb 08; 37(2):131-41. PubMed ID: 25394182
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.
    Björkdahl C, Sjögren MJ, Zhou X, Concha H, Avila J, Winblad B, Pei JJ.
    J Neurosci Res; 2008 May 01; 86(6):1343-52. PubMed ID: 18061943
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A, Hasslund K, Cowburn RF, Bäckström A, Vasänge M.
    Biochem Biophys Res Commun; 2004 Jul 02; 319(3):993-1000. PubMed ID: 15184080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.